H -tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane-j 4 N]neodymium(III) tris(perchlorate) 1.25-hydrate
Aqua(N,N′,N′′,N′′′-tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane)praseodymium(III) hexanitratopraseodymate(III) dihydrate
✍ Scribed by Richards-Johnson, Roxan U. ;Kahwa, Ishenkumba A. ;Lough, Alan J.
- Publisher
- International Union of Crystallography
- Year
- 2003
- Tongue
- English
- Weight
- 485 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
H -tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane)praseodymium(III) hexanitratopraseodymate(III) dihydrate
📜 SIMILAR VOLUMES
Crystallization of [Cd(S-thpc12)](ClO 4 ) 2 ÁH 2 O {S-thpc12 is 1,4,7,10-tetrakis[(S)-2-hydroxypropyl]-1,4,7,10-tetraazacyclo-dodecane} in the presence of sodium salicylate (sodium o-hydroxybenzoate) forms a receptor complex, namely the title compound, [Cd(C 20 H 44 N 4 O 4 )(C 7 H 5 O 3 )]ClO 4 Á0.
Single-crystal X-ray study T = 130 K Mean '(C±C) = 0.005 A Ê R factor = 0.029 wR factor = 0.067 Data-to-parameter ratio = 12.7 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.